Delivery Order SPE2DB25D3402-SPE2DB25FUGFJ

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA(CF) 40 MG/0.4 ML SYRINGS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,447.90 and a performance period that runs through June 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) 40 MG/0.4 ML SYRINGS, a specialty medication, with a ceiling value of $1,431.30 and a completion date of March 17, 2025. The contract is a Delivery Order awarded under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of HUMIRA(CF) 40 MG/0.4 ML syringes. The $1,385.37 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 25, 2024. The contract is a delivery order and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of HUMIRA(CF) 40 MG/0.4 ML SYRINGS, a pharmaceutical product. The contract has a ceiling value of $1,510.60 and is a firm fixed price delivery order. The award date is May 19, 2025, with an ultimate completion date of May 20, 2025. The contract is not set-aside and is open to...
This federal contract award is to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) 40 MG/0.4 ML SYRINGES to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,016.98 and an ultimate completion date of April 21, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical. This IDC,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) 40 MG/0.4 ML SYRINGES, a specialty pharmaceutical product. The total ceiling value of the contract is $14,228.41, with a period of performance through November 15, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award, valued at $12,040.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) 40 MG/0.4 ML SYRINGS, a specialty pharmaceutical product, with a completion date of January 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HUMIRA(CF) 40 MG/0.4 ML SYRINGS. It is a firm fixed-price delivery order with a ceiling value of $1,823.76 and an ultimate completion date of June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,405.05, is for the delivery of HUMIRA(CF) 40 MG/0.4 ML SYRINGES, a specialty pharmaceutical product. The contract has an ultimate completion date of July 24, 2024 and is a Firm Fixed Price Delivery Order. The award was made on July 23, 2022 and there is no set-aside designation, indicating open...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply HUMIRA(CF) 40 MG/0.4 ML SYRINGS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,265.90 and a completion date of May 27, 2025. The contract is not set aside for any special designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB25D3402
    Indefinite Delivery Contract
  • SPE2DB25D3402-SPE2DB25FUGFJ
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA(CF) 40 MG/0.4 ML SYRINGS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a firm fixed-price delivery order with a ceiling value of $10,333.58. The contract has an ultimate completion date of June 12, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen Drug Corp with the DLA, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to various government agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/10/25, 9:48 AM